VIM
ABBV icon

Vinva Investment Management’s AbbVie ABBV Stock Holding History

Vinva Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.1M Buy
272,567
+32,537
+14% +$7.22M 0.72% 22
2025
Q4 		$55.1M Buy
240,030
+77,446
+48% +$17.6M 0.69% 24
2025
Q3 		$36.3M Buy
162,584
+31,451
+24% +$6.4M 0.71% 17
2025
Q2 		$23.9M Buy
131,133
+37,656
+40% +$7M 0.62% 30
2025
Q1 		$19.2M Buy
93,477
+1,344
+1% +$261K 0.76% 25
2024
Q4 		$16.2M Buy
92,133
+1,498
+2% +$275K 0.62% 30
2024
Q3 		$17.7M Buy
90,635
+9,937
+12% +$1.85M 0.75% 22
2024
Q2 		$13.6M Sell
80,698
-544
-0.7% -$90.1K 0.68% 21
2024
Q1 		$14.8M Buy
81,242
+2,729
+3% +$470K 0.83% 18
2023
Q4 		$12.1M Buy
78,513
+7,704
+11% +$1.12M 0.83% 21
2023
Q3 		$10.8M Buy
70,809
+17,752
+33% +$2.61M 1.01% 16
2023
Q2 		$7.07M Sell
53,057
-5,957
-10% -$874K 0.61% 35
2023
Q1 		$9.32M Buy
+59,014
New +$9.02M 0.78% 23

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vinva Investment Management's ABBV Position: Q1 2026 in Review

Vinva Investment Management increased its AbbVie (ABBV) stake by 14% in Q1 2026, buying an estimated $7.22M and bringing the position to 272,567 shares worth $58.1M. The position accounts for 0.72% of the portfolio, ranked #22.

Vinva Investment Management first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Vinva Investment Management held 272,567 shares of AbbVie worth $58.1M as of Q1 2026.
  • Vinva Investment Management bought 32,537 AbbVie shares in Q1 2026, an estimated $7.22M.
  • AbbVie made up 0.72% of Vinva Investment Management's portfolio in Q1 2026, its #22 holding.
  • Vinva Investment Management first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.